Medication info
Glimide 2mg Tablet (Glimepiride)

Glimide 2mg Tablet (Glimepiride)

Prescription medicationTabletOral
Ingredient · strength
Glimepiride›2mg / 1 tablet
Manufacturer / importer
Kuju Pharmaceutical Co., Ltd.
Appearance
Green oblong tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201403417 · Approved 2014.07.25 · Insurance code 669804400

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Individualize the dose for each patient. Swallow without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. It should be taken before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration In patients who have not previously received drug therapy, initiate treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional effect, but some patients have achieved better metabolic control with doses increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control may improve during treatment, the requirement for this medicine may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no exact dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is advisable to follow the instructions under Initial dose. That is, treatment may be initiated at 1 mg once daily, with dose adjustment at 1 ~ 2-week intervals. The potency and duration of action of the previous medicine should be considered. 4) Dose adjustment during treatment Blood glucose and/or urine glucose levels should be measured regularly while taking this medicine, and regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia can be promptly corrected by taking sugar. Hypoglycemia may recur despite successful initial management during treatment with sulfonylureas. Therefore, patients should be carefully monitored. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization may sometimes be necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy of this medicine with insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. This medicine is administered at 8 mg once daily with the first meal, while insulin is initiated at a low dose and increased at approximately one-week intervals according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin doses should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Clinical information has been published on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia with concomitant use of this medicine and metformin, and the risk may increase. Appropriate precautions should be taken.

Ingredients

Manufacturer
Kuju Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Poor blood sugar control in patients with type 2 diabetes
View approved original text

This medication is used alongside dietary control and exercise therapy to assist in the blood sugar control of patients with type 2 diabetes. It can be used alone or in conjunction with insulin or other oral hypoglycemic agents if blood sugar control is insufficient. Particularly, when the effect of monotherapy with sulfonylureas or metformin is inadequate, it is administered together with metformin to improve blood sugar control. This medication effectively assists in improving blood sugar control in patients.

How to take

Adult dose

Individualize the dose for each patient. Swallow without chewing with at least 1/2 cup of water. This medicine is administered orally once daily. It should be taken before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration In patients who have not previously received drug therapy, initiate treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional effect, but some patients have achieved better metabolic control with doses increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic medicine. 2) Subsequent dose adjustment As diabetes control may improve during treatment, the requirement for this medicine may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral hypoglycemic agent to this medicine There is no exact dose equivalence between this medicine and other oral hypoglycemic agents. When switching from another oral hypoglycemic agent to this medicine, it is advisable to follow the instructions under Initial dose. That is, treatment may be initiated at 1 mg once daily, with dose adjustment at 1 ~ 2-week intervals. The potency and duration of action of the previous medicine should be considered. 4) Dose adjustment during treatment Blood glucose and/or urine glucose levels should be measured regularly while taking this medicine, and regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia can be promptly corrected by taking sugar. Hypoglycemia may recur despite successful initial management during treatment with sulfonylureas. Therefore, patients should be carefully monitored. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization may sometimes be necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy of this medicine with insulin is used in patients with secondary failure and when fasting blood glucose (FBG) exceeds 150 mg/dL. This medicine is administered at 8 mg once daily with the first meal, while insulin is initiated at a low dose and increased at approximately one-week intervals according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. Insulin doses should be adjusted periodically while measuring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Clinical information has been published on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia with concomitant use of this medicine and metformin, and the risk may increase. Appropriate precautions should be taken.

Precautions

This medication should not be used in patients with insulin-dependent diabetes, diabetic ketoacidosis, or those in a coma. Additionally, patients who are allergic to this medication, sulfonylureas, or sulfonamides should not be administered this medication. There is no experience using this medication in patients with severe liver or kidney dysfunction, so transitioning to insulin therapy is recommended. This medication should also not be administered to pregnant women or those who may become pregnant, nor to breastfeeding women. Care must be taken in patients with severe infections, before and after surgery, or severe trauma, as insulin therapy may be required in these cases. Patients with gastrointestinal disorders, such as diarrhea or vomiting, may have impaired food absorption, increasing the risk of hypoglycemia. This medication contains lactose, so patients with lactose intolerance or specific genetic metabolic disorders should avoid taking it. During the first week of administration, the risk of hypoglycemia is high, so it is crucial to closely monitor blood sugar status. Elderly patients, those with poor nutritional status or irregular eating habits, and patients with an imbalance of exercise and carbohydrate intake should be particularly cautious if there is a change in eating patterns. Patients who frequently consume alcohol or have weakened liver or kidney function may also be at increased risk of hypoglycemia. Patients who overdose on this medication or have certain endocrine disorders, as well as those taking other medications simultaneously, must be cautious about blood sugar fluctuations. This medication can cause hypoglycemia, with symptoms such as headache, severe hunger, nausea, fatigue, anxiety, confusion, drowsiness, and decreased consciousness. Hypoglycemia can be quickly controlled by consuming sugar, so patients should always carry glucose with them. Additionally, gastrointestinal symptoms such as blurred vision, nausea, vomiting, and abdominal pain may also occur, and rare occurrences of liver dysfunction or blood abnormalities, as well as allergic reactions, can arise. If severe allergic reactions occur, medical attention should be sought immediately. This medication requires regular administration along with dietary management, exercise therapy, and, if necessary, weight management for optimal blood sugar control. It is important to adequately educate patients and their families about the symptoms and risks of hypoglycemia, as well as how to respond appropriately when it occurs. During stressful situations, such as trauma, surgery, or infections, blood sugar control may become challenging, thus temporarily transitioning to insulin therapy may be warranted. This medication is metabolized and excreted through the liver and kidneys, so dose adjustments may be needed for elderly patients with decreased renal or hepatic function. If taken with other medications, it can affect blood sugar control, so all medications being taken should be disclosed to a physician or pharmacist. Care should particularly be taken regarding interactions with beta-blockers, antibiotics, and steroids. In the case of overdose, severe hypoglycemia may occur, so immediate medical attention is required, including emergency measures such as inducing vomiting, administering activated charcoal, or glucose injection. Finally, the safety and efficacy of this medication in children have not been established, and it should not be used by pregnant or breastfeeding women. Medications should be stored out of the reach of children and kept in their original containers for safety.

Side effects

Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorders, anxiety, aggression, decreased concentration, decreased agility or activity, depression, confusion, language impairment, aphasia, visual disturbances, tremors, partial paralysis, perceptual disturbances, dizziness, weakness, loss of self-control, transient mental confusion, cerebral convulsions, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and clammy skin, tachycardia, hypertension, palpitations, angina pectoris, venous arrhythmia, blurred vision, fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, liver dysfunction, bile secretion disorder, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythropenia, agranulocytosis, pancytopenia, itching, hives, rash, respiratory distress, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, photosensitive skin reactions, decreased serum sodium concentration, taste disturbance, hair loss, weight gain, dizziness, liver dysfunction, abdominal pain, joint pain, indigestion, facial swelling, erectile dysfunction, facial flushing, gastritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it must be stored in a tightly sealed container. It is important to maintain storage temperatures between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

Green oblong tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.